MCAULAY CAMERON (Chief Financial Officer) reported 1 transaction at TRANSPHORM, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 11/21/2023ACC: 0001209191-23-056279
Officer· Chief Financial Officer
Since Feb 2020
-2.54K
Net shares
Net seller
$7.0K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
2.54K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.54K
Price / share
$2.77
Trade value
$7.02K
% of position
1.3%
11/17/2023
190.23K→187.70K
Total
Net shares
−2.54K
Net value
-$7.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/17/2023 | F · Tax Withholding | −2.54K | $2.77 | $7.02K | 1.3% | 190.23K | 187.70K |
| Total | −2.54K | -$7.02K | ||||||
Derivative Transactions0
No derivative transactions reported